Morgan Stanley Spruce Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,133 shares of SPRB stock, worth $810. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,133

Previous 2,133 -0.0%

Holding current value

$810

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$0.51 - $0.85 $9,888 - $16,481	-19,390 Reduced 90.09%	2,133 $1,000
Q2 2024 Aug 14, 2024	SELL	$0.51 - $0.85 $9,888 - $16,481	-19,390 Reduced 90.09%	2,133 $1,000
Q1 2024 Oct 17, 2024	BUY	$0.7 - $5.49 $13,573 - $106,451	19,390 Added 909.05%	21,523 $17,000
Q1 2024 Aug 16, 2024	BUY	$0.7 - $5.49 $13,573 - $106,451	19,390 Added 909.05%	21,523 $17,000
Q1 2024 May 15, 2024	BUY	$0.7 - $5.49 $13,573 - $106,451	19,390 Added 909.05%	21,523 $17,000
Q4 2023 Feb 13, 2024	BUY	$1.04 - $2.93 $2 - $5	2 Added 0.09%	2,133 $6,000
Q2 2023 Aug 14, 2023	SELL	$1.92 - $2.6 $1,956 - $2,649	-1,019 Reduced 32.35%	2,131 $4,000
Q1 2023 May 15, 2023	SELL	$1.15 - $3.17 $217 - $599	-189 Reduced 5.66%	3,150 $6,000
Q4 2022 Feb 14, 2023	SELL	$0.99 - $1.43 $19,636 - $28,364	-19,835 Reduced 85.59%	3,339 $3,000
Q3 2022 Nov 14, 2022	SELL	$1.18 - $2.19 $44,233 - $82,094	-37,486 Reduced 61.8%	23,174 $31,000
Q2 2022 Oct 27, 2022	BUY	$1.28 - $2.23 $63,025 - $109,802	49,239 Added 431.13%	60,660 $106,000
Q2 2022 Aug 15, 2022	BUY	$1.28 - $2.23 $63,025 - $109,802	49,239 Added 431.13%	60,660 $106,000
Q1 2022 Oct 27, 2022	SELL	$1.85 - $4.59 $91,092 - $226,007	-49,239 Reduced 81.17%	11,421 $22,000
Q1 2022 May 13, 2022	SELL	$1.85 - $4.59 $1,794 - $4,452	-970 Reduced 7.83%	11,421 $22,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.74 $148,001 - $364,604	-63,520 Reduced 83.68%	12,391 $55,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $11.26 $456,225 - $854,757	75,911 New	75,911 $456,000

Others Institutions Holding SPRB

# of Institutions

Shares Held

15.4M

Call Options Held

16.7K

Put Options Held

1.1K

View Full List

About SPRUCE BIOSCIENCES, INC.

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $8.95M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

More about SPRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account